ADVFN US – Market Content Editor

  • Dow Jones, S&P, Nasdaq, Wall Street Futures, U.S. Markets Seen Treading Water After Mixed Employment Signals

    Dow Jones, S&P, Nasdaq, Wall Street Futures, U.S. Markets Seen Treading Water After Mixed Employment Signals

    U.S. stock index futures pointed to a largely flat start on Tuesday, suggesting Wall Street could struggle to find clear direction after closing the previous session slightly lower following volatile trading. Investors appear cautious as they assess a mixed set of U.S. labor market figures, making it difficult to draw firm conclusions about the strength…

  • Wall Street Banks Wary as U.S. Markets Move Toward 24-Hour Stock Trading

    Wall Street Banks Wary as U.S. Markets Move Toward 24-Hour Stock Trading

    U.S. equity markets are edging closer to round-the-clock trading, but enthusiasm across Wall Street is mixed, with several major banks taking a cautious stance toward the shift. While exchanges are moving ahead with plans for nearly continuous weekday trading as early as late next year, some of the largest U.S. banks remain hesitant to fully…

  • Smartphone Shipments Seen Falling in 2026 as Higher Chip Costs Weigh on Demand

    Smartphone Shipments Seen Falling in 2026 as Higher Chip Costs Weigh on Demand

    Global smartphone shipments are expected to decline by 2.1% in 2026, as rising semiconductor costs begin to dampen consumer demand, according to a report released Tuesday by technology research firm Counterpoint. Electronics supply chains have recently been grappling with shortages of so-called legacy memory chips. Chipmakers have increasingly redirected capacity toward advanced memory used in…

  • Pfizer Sets Out 2026 Outlook, Signalling Softer Revenue and Earnings

    Pfizer Sets Out 2026 Outlook, Signalling Softer Revenue and Earnings

    Pfizer Inc. (NYSE:PFE) has released its financial outlook for 2026, forecasting revenue in a range of $59.5 billion to $62.5 billion and adjusted diluted earnings per share between $2.80 and $3.00. At the same time, the pharmaceutical group updated its guidance for 2025, now expecting revenue of about $62.0 billion, compared with its earlier forecast…

  • BofA Selects Estée Lauder as Its Leading Beauty Stock for 2026

    BofA Selects Estée Lauder as Its Leading Beauty Stock for 2026

    Bank of America has identified Estée Lauder Companies (NYSE:EL) as its preferred beauty stock for 2026, highlighting growing confidence in the company’s turnaround efforts alongside a more favorable outlook for the sector. In a research note maintaining a Buy recommendation, BofA analyst Ashley Wallace said the bank has lifted its price target on the shares…

  • Kraft Heinz Appoints Steve Cahillane as CEO Starting January 2026

    Kraft Heinz Appoints Steve Cahillane as CEO Starting January 2026

    The Kraft Heinz Company (NASDAQ:KHC) said Steve Cahillane will take over as chief executive officer effective January 1, 2026. Current CEO Carlos Abrams-Rivera will step down at that time and remain with the company in an advisory role through March 6, 2026. Cahillane will also join Kraft Heinz’s Board of Directors and assume leadership of…

  • Duluth Holdings Shares Jump After Q3 Loss Narrows and Earnings Top Forecasts

    Duluth Holdings Shares Jump After Q3 Loss Narrows and Earnings Top Forecasts

    Duluth Holdings Inc. (NASDAQ:DLTH) reported third-quarter results on Tuesday that showed a smaller loss than expected, helping lift the retailer’s shares despite revenue coming in below market forecasts. The workwear and casual clothing group saw its stock rise 6.39% in pre-market trading following the announcement. For the quarter, Duluth posted an adjusted loss of $0.23…

  • Nektar Posts Mixed Phase 2b Data for Alopecia Areata Treatment

    Nektar Posts Mixed Phase 2b Data for Alopecia Areata Treatment

    Nektar Therapeutics (NASDAQ:NKTR) reported results from its Phase 2b REZOLVE-AA study evaluating rezpegaldesleukin in patients with severe to very severe alopecia areata, with the trial narrowly missing its primary efficacy endpoint. The study enrolled 92 patients who were randomly assigned to receive rezpegaldesleukin at doses of either 24 µg/kg or 18 µg/kg, or a placebo.…

  • Brand House Collective Shares Slide After Weak Q3 Results

    Brand House Collective Shares Slide After Weak Q3 Results

    Shares of The Brand House Collective, Inc. (NASDAQ:TBHC) dropped about 6% on Tuesday after the home furnishings retailer posted third-quarter results that fell well short of market expectations, reflecting pressure from inventory clearance activities and a sharp slowdown in online sales. The stock was down 5.98% in pre-market trading following the release. Formerly known as…

  • Energous Shares Jump on EU Clearance for PowerBridge Pro

    Energous Shares Jump on EU Clearance for PowerBridge Pro

    Energous Corporation (NASDAQ:WATT) shares rallied around 14% after the wireless power technology company said its PowerBridge Pro Directional transmitter has secured regulatory approval for use across the European Union. The authorization allows Energous to commercially deploy its flagship wireless power transmitter throughout all EU member states as well as the UK. PowerBridge Pro is capable…